ITTOY Stock UPDATES Itochu Techno-So ADR (ITTOY) 22.3600 08/03/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Itochu Techno-So ADR (ITTOY) 22.3600 $ITTOY

Rakuten Mart CEO to Keynote Descartes & CTC Omni-Channel Retail & Home Delivery Summit in Japan
GlobeNewswire - Tue Jun 10, 5:45AM CDT
Descartes Systems Group (TSX SG) (Nasdaq SGX), the global leader in uniting logistics-intensive businesses in commerce, announced that in collaboration with United by Design partner, ITOCHU Techno-Solutions Corporation (CTC), it will host an Omni-channel Retail and Home Delivery Summit in Japan. They keynote speaker will be Kitta Naohiko, CEO of Rakuten Mart, a leading online supermarket wholly owned by Japan's top e-commerce company, Rakuten Inc. Rakuten Mart is a CTC/Descartes customer.

Japan's ITOCHU Techno-Solutions Corporation (CTC) Selects MarkLogic(R) Enterprise NoSQL Database Platform to Expand Big Data Services
Business Wire - Wed Feb 05, 7:00AM CST
MarkLogic Corporation, the leading Enterprise NoSQL database platform company, today announced the expansion of its global partner network with the addition of ITOCHU Techno-Solutions Corporation (CTC), a company providing comprehensive support for the IT lifecycle. Based in Japan, CTC will deliver Big Data solutions based on the MarkLogic Enterprise NoSQL database platform.

Goto AZ Planning Automates Home Delivery Service in Japan With Cloud-Based Descartes/CTC Solution
GlobeNewswire - Wed Sep 11, 5:45AM CDT
Descartes Systems Group (Nasdaq SGX) (TSX SG), the global leader in uniting logistics-intensive businesses in commerce, announced that Goto AZ Planning, a leading home care rental company in Japan, has automated its home delivery operations with a combined cloud-based solution from Descartes and ITOCHU Techno-Solutions Corporation (CTC), a Descartes 'United by Design' partner.

CTC and ITOCHU Strengthen Collaboration in Domestic Development and Commercialization of Overseas Cloud Services
M2 - Mon Jul 22, 5:43AM CDT
ITOCHU Techno-Solutions Corporation (headquartered in Chiyoda-ku, Tokyo; Satoshi Kikuchi, President & CEO; hereinafter "CTC" and ITOCHU Corporation (headquartered in Minato-ku, Tokyo; Masahiro Okafuji, President & CEO; hereinafter "ITOCHU" announced today that the companies will step up collaboration to, within Japan, develop high-quality cloud services originating in the United States and other countries.

Big Switch Networks Enters Rapidly Developing Japanese Market With Software Defined Networking (SDN) Partners
Business Wire - Tue Mar 05, 8:00AM CST
Big Switch Networks today announced distribution partnerships with ITOCHU Techno-Solutions Corporation (CTC) and Net One Systems to address the growing demand in Japan for Network Virtualization and Open Software-Defined Networking (SDN) solutions. Big Switch Networks' Open SDN product suite includes an SDN controller that serves as a network application platform for a variety of applications, including network monitoring and data center network virtualization.

CSC Agrees to Sell Southeast Asia Reseller Unit
M2 - Thu Feb 21, 8:48AM CST
CSC has reached a definitive agreement with a consortium comprising ITOCHU Techno-Solutions Corporation ("CTC" and ITOCHU Corporation for the sale of CSC's Enterprise Systems Integration (ESI) unit, a reseller of enterprise hardware and software and a provider of maintenance services with operations in Malaysia and Singapore, for $90 million in cash.



Scroll down for more posts ▼

Top 10 Most Recent News Articles

Two Xinjiang Histories Arrive With a Clear State Lens

Updated Category News Views 162

Dusty chronology rarely carries this much present-day weight. Two books released in Beijing on September 2, The History of China's Xinjiang Region and The Religious History in China's Xinjiang Region, are presented as the most comprehensive works on the subject yet produced by Chinese scholars. That is a sizable claim, and it deserves to be read with both attention and a...

Continue Reading
BioVersys AlpE Data Offers a Measured TB Treatment Signal

Updated Category News Views 80

Tuberculosis drug development rarely hands anybody a clean victory lap, and BioVersys' latest readout is no exception. The completed 14-day Phase 2a ENABLE study gives alpibectir plus ethionamide, known as AlpE, a credible early clinical signal in newly diagnosed drug-sensitive pulmonary TB. That matters. It does not, however, settle the far larger question of whether...

Continue Reading
CVS Puts Youth Soccer Stories on Its Store Shelves

Updated Category News Views 0

Two kids with real community ties just got a megaphone most grown-ups never receive. CVS Pharmacy has named Caroline, 9, of Holmes Beach, Florida, and Zoe, 12, of Los Angeles, as the first grand-prize winners of its Home Team Heroes youth soccer contest. Each player’s selected nonprofit soccer organization will receive a $25,000 grant, while their stories will appear on...

Continue Reading
TD Pledges $2 Billion to Financial Strength by 2036

Updated Category News Views 83

A Longer-Term Bet on Household Resilience A bank’s community budget rarely grabs the market by the collar, but TD’s new target deserves more than a polite nod. The bank says it will direct $2 billion, or US$1.4 billion, toward helping people build financial strength across North America over the next decade. That is a sizable commitment, even for an institution with...

Continue Reading
TCL CSOT's Oxide Leap Gives LCD a Sharper Fight Ahead

Updated Category News Views 59

Fifty-one point six is the number that makes this announcement worth chewing on. TCL CSOT says it has moved ultrahigh-mobility oxide technology into mass production on an 8.6-generation line, clearing the 50 cm² V?¹ s?¹ threshold that has largely belonged to lab-talk and presentation slides. For display people, that is not decorative science. It could change the old...

Continue Reading
D-Wave Investors Face December 15 Lead Plaintiff Clock

Updated Category News Views 19

Quantum dreams met a very earthly spreadsheet problem at D-Wave this summer. The proposed securities class action against D-Wave Quantum Inc. puts a hard date on the issue for investors who bought shares between February 26 and August 25, 2026: December 15, 2026 is the deadline to seek lead-plaintiff status. That does not mean every holder needs to march into court. It...

Continue Reading
RMT’s 12.4% Discount Still Demands a Much Harder Look

Updated Category News Views 119

A $1.84 gap is staring RMT shareholders right in the face. As of October 31, 2026, Royce Micro-Cap Trust carried a net asset value of $14.82 per share while the market price sat at $12.98. That is roughly a 12.4% discount to NAV, and closed-end fund investors should never wave off a spread like that with a lazy shrug. It may be opportunity. It may also be the market...

Continue Reading
Clickstop's Urbana Expansion Bets on Durable Demand

Updated Category News Views 126

A patch of turned Iowa dirt can say plenty about a company’s nerve. Clickstop broke ground in Urbana on Nov. 19, 2026, for a 43,000-square-foot building, and the message is pretty plain: management believes its recent growth has legs. For a privately held, employee-owned operator serving trucking, construction, lifting and rigging, that is not a casual decision....

Continue Reading
Sleep Number’s Couples Pitch Has Some Fine Print Too

Updated Category News Views 40

A thermostat war in the bedroom is a lousy reason to buy the wrong mattress. Yet that is the mundane, very real problem Sleep Number is leaning into after Expert Consumers named it a leading 2026 choice for couples seeking personalized sleep comfort. The company’s argument is straightforward: two people sharing a bed should not have to share one firmness setting, or...

Continue Reading
Cloud Optical Demand Is Running Ahead of Supply in 2026

Updated Category News Views 20

Fiber capacity has become the awkward bottleneck nobody can wish away. Dell’Oro Group says the optical transport equipment market expanded 24% year over year in the third quarter of 2026, with large North American cloud providers doing the heavy lifting. More pointedly, optical vendor revenue tied to those cloud customers jumped 75%. That is not a gentle improvement in...

Continue Reading

Top 5 Most Recently Viewed Articles

Raphael Bostic's Forecast for Interest Rate Cuts in 2024

Updated Category News Views 139

Fed's Bostic Discusses Future Interest Rate Cuts Atlanta Federal Reserve President Raphael Bostic has recently shared his insights regarding future interest rate adjustments. At a recent event in Atlanta, Bostic indicated that he has projected a further interest rate decrease of 25 basis points this year. This update follows his review of the central bank's recent...

Continue Reading
Boardwalktech Software to Showcase Innovations at Upcoming Event

Updated Category News Views 169

Boardwalktech Software Demonstrates Commitment to Innovation Boardwalktech Software Corp. (TSXV: BWLK) (OTCQB: BWLKF), recognized as a leader in the Intelligent Information Platform sector, has announced that their CEO and Chairman, Andrew Duncan, is set to present at the highly anticipated Planet MicroCap Showcase. This event, in partnership with MicroCapClub, serves as...

Continue Reading
Michael Saylor Advocates for U.S. Leadership in Cryptocurrency

Updated Category News Views 123

Michael Saylor's Vision for Digital Assets Michael Saylor, the co-founder of Strategy Inc. and a prominent advocate for Bitcoin, recently held discussions with key figures in the House Financial Services Committee. His conversations focused on strategies to position the United States as a leading authority in the world of Bitcoin and cryptocurrencies. The Digital Assets...

Continue Reading
Gents Doctor Unveils Insights on Testosterone Therapy and Health

Updated Category News Views 297

Gents Doctor Shares New Insights on Testosterone Therapy Gents Doctor, a well-known male health clinic led by Dr. Majid Sabour, MD, has recently unveiled two important blog posts that explore significant topics related to Testosterone Replacement Therapy (TRT). These posts are designed to inform men who are interested in improving their health through hormone...

Continue Reading
Promising Results from Phase III POLARIS-1 Study of Olverembatinib

Updated Category News Views 233

Exciting Developments in the Treatment of Ph+ ALL At the recent American Society of Hematology (ASH) meeting, cutting-edge research on Olverembatinib, a promising drug from Ascentage Pharma, highlighted its impressive efficacy for patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). The findings from the Phase III...

Continue Reading